Searchable abstracts of presentations at key conferences in endocrinology

ea0016p272 | Endocrine tumours | ECE2008

Special multiple endocrine neoplasia (MEN)

Santiago Piedad , Ramirez Cesar , Ruiz Isabel , Martinez Pilar , Lopez Jose Antonio , Sanchez Carolina , Moreno Alberto

The ‘Multiple Endocrine Neoplasia’ predominantly affect the pituitary gland, parathyroids, thyroids, adrenal glands and pancreas. We present the case of a patient with three different functioning endocrine gland tumours, but who cannot be included in any of these groups.Case report: Sixty-five-years-old female with recurrent episodes of nephritic colic and hypertension for 2 years; non-specific gastrointestinal complaints, hirsutism, hyp...

ea0063ep40 | Diabetes, Obesity and Metabolism | ECE2019

Afraid that your prediabetic patients may develop type 2 diabetes with statins? Give red yeast rice + berberin a try!

Kuzior Agnieszka , Nivelo-Rivadeneira Manuel Esteban , Fernandez-Trujillo-Comenge Paula Maria , Santana-Suarez Ana Delia , Acosta-Calero Carmen , Gonzalez-Diaz Paula , Dieguez-Moreno Alberto , Martinez-Martin Francisco Javier

Aim: To establish the effect of a supplement containing 250 mg red yeast rice extract, 525 mg berberine and 50 mg coenzyme Q10 on insulin sensitivity in patients with hypercholesterolemia and prediabetes.Methods: For this open, uncontrolled study, patients of age 30–75 years, with hypercholesterolemia (LDL cholesterol >130 mg/dl and triglycerides <300 mg/dl), and prediabetes without overt cardiovascular disease, untreated in the previous 6 m...

ea0035oc12.2 | Pituitary Basic | ECE2014

Differential in vitro response to octreotide and pasireotide in normal and tumoral primary pituitary cell cultures

Ibanez-Costa Alejandro , Gahete Manuel David , Jimenez-Reina Luis , Rivero-Cortes Esther , Lopez-Sanchez Laura Maria , Galvez Maria Angeles , de la Riva Andres , Benito-Lopez Pedro , Venegas-Moreno Eva , Angel Japon Miguel , Moreno Alberto , Garcia-Arnes Juan Antonio , Maraver-Selfa Silvia , Angel Arraez Miguel , Leal-Cerro Alfonso , Schmid Herbert A. , Tinahones Francisco J. , Soto-Moreno Alfonso , Castano Justo P. , Luque Raul M.

Somatostatin analogs (SSA) are a first-line treatment for pituitary adenomas (PA). Indeed, multi-receptor targeting SSA such as octreotide and pasireotide are being successfully used to control hormone secretion and/or tumor growth. Unfortunately, many PA escape from SSA-therapy, which could be related to somatostatin receptor (sst) presence, abundance, availability and/or signaling. In order to better define the molecular/cellular features associated to octreotide and pasireo...